PAREXEL - Early Phase Unit — Glendale, California

PAREXEL - Early Phase Unit is a clinical research site located in Glendale, California, United States 91206.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

PAREXEL - Early Phase Unit has participated in 1 clinical trials.

Therapeutic areas: Healthy Subjects, Pharmacokinetics of ASP015K.

Sponsors: Astellas Pharma Global Development, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Glendale

Browse all research sites in California · View every site in Glendale

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for PAREXEL - Early Phase Unit?

PAREXEL - Early Phase Unit has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has PAREXEL - Early Phase Unit conducted?

PAREXEL - Early Phase Unit has 1 clinical trials on record. Their work covers Healthy Subjects, Pharmacokinetics of ASP015K.

Is PAREXEL - Early Phase Unit accredited by Crixeo Clinical Trials?

PAREXEL - Early Phase Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about PAREXEL - Early Phase Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.